Navigation Links
Curemark Appoints Dr. Elisa J. Zinberg as Vice President of Operations
Date:9/23/2008

Curemark is pleased to announce the appointment of Dr. Elisa J. Zinberg as Vice - President of Operations, and member of Curemark’s management team, effective immediately.

Rye, NY (PRWEB) September 23, 2008 -- Curemark is pleased to announce the appointment of Dr. Elisa J. Zinberg as Vice - President of Operations, and member of Curemark’s management team, effective immediately. Dr. Zinberg will be responsible for the day-to-day management of Curemark as well as for the implementation of Curemark’s strategic plan.

“In addition to having an outstanding track record in the health care field, Dr. Zinberg brings a tremendous level of expertise, energy and business acumen to Curemark,” states Dr. Joan Fallon, Curemark’s CEO. “We are honored to have someone of Dr. Zinberg’s caliber as Curemark’s new Vice–President of Operations.”

Dr. Zinberg was previously the Chief Operating Officer of a privately held multi-million dollar health care corporation, The Masters Circle. The Masters Circle provides consulting services to the health care sector within the United States and internationally.

“As Curemark is preparing to enter clinical trials for its proprietary drug for autism, Dr. Zinberg joins us at a most historic time,” states Dr. Matthew Heil, Vice-President for Drug Development and Manufacturing for Curemark. “She will help lead us into the next phases of our company development, and implementation of our strategic plan for our vast array of clinical targets.”

Curemark is a biotechnology company focused on the treatment of neurological and other diseases by addressing certain key gastrointestinal/pancreatic secretory deficiencies. The company’s initial products are based upon breakthrough observations by its founder, Dr. Joan Fallon. The company is currently preparing for clinical trials. To learn more about our innovative science, please visit: www.cure-mark.com.

Media Contact:
Alissa Minio
info @ cure-mark.com
(914) 925-3450

###

Read the full story at http://www.prweb.com/releases/2008/09/prweb1366754.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. Curemark CEO Presents Autism Findings at Prestigious Neurobiology Conference at Oxford
2. US Oncology Appoints Michael A. Sicuro Executive Vice President and Chief Financial Officer
3. Wolters Kluwer Health Appoints Scott Lubeck Vice President, Technology of its Professional & Education Unit
4. Millennium Pharmacy Systems, Inc. Appoints New CEO
5. National Coalition for Quality Colorectal Cancer Screening and Care Appoints New Executive Director, Randall H. H. Madry:
6. U.S. Preventive Medicine Appoints Ron Loeppke, M.D. as Co-Chairman of Its National Advisory Board
7. Sunrise Senior Living Appoints Glyn Aeppel and David Fuente to its Board
8. VirtualHealth Technologies, Inc., Announces Its Associate, Private Access, Appoints Marc Kirshbaum as President & COO
9. Cadient Group Appoints Andrew le Blanc as Creative Director
10. Quorum Review IRB Appoints Michael Malafronte Director of Quality and Document Administration
11. Sonic Innovations Appoints New President and COO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , ... June 27, 2016 , ... ... edge technology to revolutionize the emergency ambulance transport experience for the millions of ... of how Uber has disrupted the taxi industry through the use of technology. ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media ... give their videos a whole new perspective by using the title layers in ... Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... Washington, D.C. (PRWEB) , ... June 25, 2016 ... ... will discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June ... share their work on several important health care topics including advance care planning, ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: